BIOAVAILABILITY OF GLI/METXR (4/850 mg)

NCT01437800 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Glimepiride / Extended release Metformin (4/850 mg).

Sponsor

Laboratorios Silanes S.A. de C.V.

Collaborators

[object Object]